Cargando…

Promising Blood Biomarkers for Clinical Use in Alzheimer’s Disease: A Focused Update

Alzheimer’s disease (AD) is the most-common cause of neurodegenerative dementia, and it is characterized by abnormal amyloid and tau accumulation, which indicates neurodegeneration. AD has mostly been diagnosed clinically. However, ligand-specific positron emission tomography (PET) imaging, such as...

Descripción completa

Detalles Bibliográficos
Autores principales:	Park, Sun Ah, Jang, Yu Jung, Kim, Min Kyoung, Lee, Sun Min, Moon, So Young
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Neurological Association 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9262460/ https://www.ncbi.nlm.nih.gov/pubmed/35796265 http://dx.doi.org/10.3988/jcn.2022.18.4.401

Ejemplares similares

Diagnostic Blood Biomarkers in Alzheimer’s Disease
por: Park, Jung Eun, et al.
Publicado: (2022)

Oligomeric forms of amyloid-β protein in plasma as a potential blood-based biomarker for Alzheimer’s disease
por: Wang, Min Jeong, et al.
Publicado: (2017)

An Update on Endodontic Microsurgery of Mandibular Molars: A Focused Review
por: Jang, Sun Mi, et al.
Publicado: (2021)

Evaluation of coexistence of Alzheimer’s disease in idiopathic normal pressure hydrocephalus using ELISA analyses for CSF biomarkers
por: Lim, Tae Sung, et al.
Publicado: (2014)

The clinical promise of biomarkers of synapse damage or loss in Alzheimer’s disease
por: Colom-Cadena, Martí, et al.
Publicado: (2020)

CSF and blood Kallikrein-8: a promising early biomarker for Alzheimer’s disease
por: Teuber-Hanselmann, Sarah, et al.
Publicado: (2020)

Diagnostic Tools for Alzheimer’s Disease: A Narrative Review Based on Our Own Research Experience
por: Park, So-Hee, et al.
Publicado: (2023)

Amyloid Beta and Tau as Alzheimer’s Disease Blood Biomarkers: Promise From New Technologies
por: Lue, Lih-Fen, et al.
Publicado: (2017)

Flotillin: A Promising Biomarker for Alzheimer’s Disease
por: Angelopoulou, Efthalia, et al.
Publicado: (2020)

Cerebrospinal Fluid Biomarkers for the Diagnosis of Alzheimer Disease in South Korea
por: Park, Sun Ah, et al.
Publicado: (2017)

A Therapeutic Strategy for Alzheimer's Disease Focused on Immune-inflammatory Modulation
por: Kim, Seung Hyun, et al.
Publicado: (2019)

Sleep as a Novel Biomarker and a Promising Therapeutic Target for Cerebral Small Vessel Disease: A Review Focusing on Alzheimer’s Disease and the Blood-Brain Barrier
por: Semyachkina-Glushkovskaya, Oxana, et al.
Publicado: (2020)

Blood cadmium levels and Alzheimer’s disease mortality risk in older US adults
por: Min, Jin-young, et al.
Publicado: (2016)

Disruption of blood-brain barrier in Alzheimer disease pathogenesis
por: Kook, Sun-Young, et al.
Publicado: (2013)

Integration of amyloid-β oligomerization tendency as a plasma biomarker in Alzheimer's disease diagnosis
por: Pyun, Jung-Min, et al.
Publicado: (2023)

The clinical use of blood-test factors for Alzheimer’s disease: improving the prediction of cerebral amyloid deposition by the QPLEX(TM)Alz plus assay kit
por: Kim, Haeng Jun, et al.
Publicado: (2021)

Peripheral Biomarkers for Alzheimer’s Disease: Update and Progress
por: Sabbagh, Marwan N., et al.
Publicado: (2019)

New fluid biomarkers tracking non-amyloid-β and non-tau pathology in Alzheimer’s disease
por: Park, Sun Ah, et al.
Publicado: (2020)

Blood Loss and Related Laboratory Changes after Single-Event Multilevel Surgery and Hip Reconstructive Surgery in Patients with Cerebral Palsy
por: Min, Jae Jung, et al.
Publicado: (2021)

Promising effects of 3rd line cyclophosphamide, adriamycin and vincristine (CAV) and 4th line ifosfamide and carboplatin chemotherapy in refractory small cell lung cancer
por: Jung, Sang Ok, et al.
Publicado: (2015)

Development of Alzheimer’s Disease Biomarkers: From CSF- to Blood-Based Biomarkers
por: Mankhong, Sakulrat, et al.
Publicado: (2022)

Alpha-2-Macroglobulin as a New Promising Biomarker Improving the Diagnostic Sensitivity of Bovine Paratuberculosis
por: Park, Hyun-Eui, et al.
Publicado: (2021)

Cerebrospinal Fluid Biomarkers for the Diagnosis of Prodromal Alzheimer's Disease in Amnestic Mild Cognitive Impairment
por: Park, Jung Eun, et al.
Publicado: (2019)

Biomarkers for the Clinical Diagnosis of Alzheimer’s Disease: Metabolomics Analysis of Brain Tissue and Blood
por: Wang, Yang-Yang, et al.
Publicado: (2021)

The strategic biomarker roadmap for the validation of Alzheimer’s diagnostic biomarkers: methodological update
por: Boccardi, Marina, et al.
Publicado: (2021)

Detection of Plasma Biomarkers Using Immunomagnetic Reduction: A Promising Method for the Early Diagnosis of Alzheimer’s Disease
por: Yang, Shieh-Yueh, et al.
Publicado: (2017)

The 2022 focused update of the 2018 Korean Hypertension Society Guidelines for the management of hypertension
por: Kim, Hack-Lyoung, et al.
Publicado: (2023)

Blood biomarkers for Alzheimer’s disease
por: Lovestone, Simon
Publicado: (2014)

Blood Biomarkers in Alzheimer’s Disease
por: Mandal, Pravat K., et al.
Publicado: (2023)

Visualization of Altered Hippocampal Connectivity in an Animal Model of Alzheimer’s Disease
por: Jeon, Seong Gak, et al.
Publicado: (2018)

Association of blood-based transcriptional risk scores with biomarkers for Alzheimer disease
por: Park, Young Ho, et al.
Publicado: (2020)

CircRNAs as promising biomarker in diagnosis of breast cancer: An updated meta‐analysis
por: Chu, Mingyu, et al.
Publicado: (2021)

Clinically accurate diagnosis of Alzheimer’s disease via multiplexed sensing of core biomarkers in human plasma
por: Kim, Kayoung, et al.
Publicado: (2020)

An Update on Sepsis Biomarkers
por: Kim, Mi-Hee, et al.
Publicado: (2020)

Emerging Alzheimer’s disease therapeutics: promising insights from lipid metabolism and microglia-focused interventions
por: Tobeh, Nour S., et al.
Publicado: (2023)

Blood amyloid-β oligomerization associated with neurodegeneration of Alzheimer’s disease
por: Youn, Young Chul, et al.
Publicado: (2019)

The Promising Biomarker for Multiple Clinical Situations
por: Sadeghi, Mohammad Reza
Publicado: (2014)

Agranulocytosis Induced by Ethambutol in a Patient with Pulmonary Tuberculosis
por: Moon, Kyoung Min, et al.
Publicado: (2015)

Update on the core and developing cerebrospinal fluid biomarkers for Alzheimer disease
por: Babić, Mirjana, et al.
Publicado: (2014)

Promise and Challenge: The Lens Model as a Biomarker for Early Diagnosis of Alzheimer's Disease
por: Tian, Tian, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_nlcb93kbd576bgf3qknhh3m1t4